Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FVR, Tampereen rokotetutkimusklinikka

Research site

Finland Tullikatu 6, 4. krs, 33100 Tampere, Finland

  • 1 trial recruiting
  • Pneumococcal immunisation
  • Children and adolescents

About Specializations

FVR, Tampereen rokotetutkimusklinikka in Tampere, Finland specialises in clinical trials of conditions such as Pneumococcal immunisation, and other specialisations. This site conducts important research.

Main research areas of the site

Pneumococcal Vaccine Safety Research

The research at FVR, Tampereen rokotetutkimusklinikka concentrates on bacterial infections with a focus on pneumococcal immunisation, aiming to assess the safety and immune response of new vaccine candidates.

  • Safety profiling of an expanded pneumococcal vaccine in healthy infants
  • Evaluation of tolerability and immune response in children and adolescents

These studies support the development of more effective prevention strategies against pneumococcal disease and contribute valuable data on vaccine safety for the pediatric population.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Tullikatu 6, 4. krs33100 TampereFinland
Open in maps ↗
Recruiting now
1 trial
Conditions studied
1

More sites in TampereFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Pneumococcal immunisation

Recruiting

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Pneumococcal immunisation

Not yet recruiting

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.